These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 29102678)
1. A monoclonal antibody raised against a thermo-stabilised β Soave M; Cseke G; Hutchings CJ; Brown AJH; Woolard J; Hill SJ Biochem Pharmacol; 2018 Jan; 147():38-54. PubMed ID: 29102678 [TBL] [Abstract][Full Text] [Related]
2. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor. Baker JG; Proudman RG; Tate CG Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538 [TBL] [Abstract][Full Text] [Related]
3. Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation. Gherbi K; May LT; Baker JG; Briddon SJ; Hill SJ FASEB J; 2015 Jul; 29(7):2859-71. PubMed ID: 25837585 [TBL] [Abstract][Full Text] [Related]
4. A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors. Baker JG PLoS One; 2010 Nov; 5(11):e15487. PubMed ID: 21152092 [TBL] [Abstract][Full Text] [Related]
5. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor. Baker JG; Proudman RG; Hill SJ Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857 [TBL] [Abstract][Full Text] [Related]
6. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530 [TBL] [Abstract][Full Text] [Related]
7. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium. Sarsero D; Molenaar P; Kaumann AJ Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376 [TBL] [Abstract][Full Text] [Related]
8. Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptor. Baker JG; Proudman RG; Hawley NC; Fischer PM; Hill SJ Mol Pharmacol; 2008 Nov; 74(5):1246-60. PubMed ID: 18687809 [TBL] [Abstract][Full Text] [Related]
9. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Baker JG Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528 [TBL] [Abstract][Full Text] [Related]
10. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists. Kitagawa Y; Adachi-Akahane S; Nagao T Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230 [TBL] [Abstract][Full Text] [Related]
11. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Gherbi K; Briddon SJ; Hill SJ Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258 [TBL] [Abstract][Full Text] [Related]
12. Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor. Baker JG; Hall IP; Hill SJ Mol Pharmacol; 2003 Jun; 63(6):1312-21. PubMed ID: 12761341 [TBL] [Abstract][Full Text] [Related]
13. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106 [TBL] [Abstract][Full Text] [Related]
14. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat. D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727 [TBL] [Abstract][Full Text] [Related]
15. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430 [TBL] [Abstract][Full Text] [Related]
16. Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domains. Baker JG; Proudman RG; Hill SJ Mol Pharmacol; 2015 Jan; 87(1):103-20. PubMed ID: 25324048 [TBL] [Abstract][Full Text] [Related]
18. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes. Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849 [TBL] [Abstract][Full Text] [Related]
19. Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the beta1-adrenoceptor. Joseph SS; Colledge WH; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):223-6. PubMed ID: 15322738 [TBL] [Abstract][Full Text] [Related]
20. (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor. Sarsero D; Russell FD; Lynham JA; Rabnott G; Yang I; Fong KM; Li L; Kaumann AJ; Molenaar P Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):10-21. PubMed ID: 12616336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]